Core Viewpoint - The article highlights the dedication and innovative contributions of Zhu Kaili, the deputy factory director of Xinjiang Tianshan Wool Textile Co., Ltd, emphasizing his journey from a dyeing worker to a leadership role, and his focus on improving production efficiency and product quality through innovation and team building [1][5]. Group 1: Career Development and Achievements - Zhu Kaili has worked at Tianshan Textile since 1994, starting as a dyeing worker and advancing to deputy factory director, showcasing a commitment to learning and technical mastery [1][2]. - Under Zhu's leadership, the first-class rate of coarse wool cashmere yarn has consistently remained at 99.9%, and the carding workshop has achieved an annual production of approximately 260 tons of various yarns [2][3]. Group 2: Innovation and Efficiency Improvements - Zhu has implemented several innovative solutions, such as a "boiler steam return water heat recovery device," which saves approximately 202,500 yuan in gas costs annually [3]. - The digital transformation of carding machines has increased production efficiency by over 3.0%, allowing for an additional 16.2 tons of yarn to be produced each year [3][4]. Group 3: Team Building and Knowledge Transfer - Zhu emphasizes the importance of team building and knowledge transfer, establishing a craftsman innovation studio that focuses on training younger workers and sharing technical expertise [6][7]. - The innovation studio collaborates with Xi'an University of Engineering to develop low-temperature bleaching technology, reducing energy consumption by 30% [7]. Group 4: Recognition and Future Aspirations - Zhu has received multiple accolades for his contributions to innovation, including the "Five Small Talents" title and the National May Day Labor Medal, reflecting his impact on the industry [5][8]. - He remains committed to continuous improvement and aims to inspire colleagues to achieve better results for the company [8].

Core Viewpoint - The A-share market saw a collective rise in industrial hemp concept stocks, driven by potential regulatory changes regarding cannabis classification in the U.S. [1][2] Group 1: Stock Performance - Fu'an Pharmaceutical (300194) increased by 15.02%, with a total market capitalization of 63.77 billion [2] - Rhine Biology (002166) reached a 10% limit up, with a market cap of 68.23 billion [2] - Morning Light Biology (300138) rose by 6.38%, with a market cap of 69.32 billion [2] - Dezhan Health (000813) saw a 4.39% increase, with a market cap of 94.79 billion [2] - Shunhao Co. (002565) and Kang En Bei (600572) increased by 3.65% and 3.25%, with market caps of 90.42 billion and 120 billion respectively [2] Group 2: Regulatory News - The Washington Post reported that Trump expressed interest in reclassifying cannabis as a lower-risk drug during a fundraising dinner, which could simplify the buying and selling process of cannabis [3] - This potential regulatory change could make the multi-billion dollar cannabis industry more profitable [3]

Core Viewpoint - Dezheng Health is actively developing an innovative drug project, WYY, aimed at treating stroke as a neuroprotective agent, with plans for IND application submission within the year [2] Group 1: Product Development - WYY is a self-developed innovative drug project by the company [2] - The company is preparing for the IND application for the WYY injection form and plans to submit it within the current year [2] - The company is also advancing research on the sublingual tablet form of WYY [2] Group 2: Regulatory Compliance - The company will fulfill disclosure obligations in accordance with regulatory requirements based on the progress of related matters [2]

Group 1 - The company, Dezhan Health, stated on August 11 that it currently does not produce or sell mosquito repellent water or sprays [2]

（文章来源：证券日报） 证券日报网讯德展健康8月11日在互动平台回答投资者提问时表示，公司官网展示药品均为前期已获得 生产批件的成熟品种，2025年目前暂未有新增批件。公司将继续积极推动新药研发工作，为患者提供更 多优质的治疗选择。 ...

Core Viewpoint - The company emphasizes the importance of market value management and is actively implementing measures to enhance its internal value and shareholder returns [1] Group 1: Market Value Management - The company has established a standardized management system through the formulation of the "Market Value Management System" [1] - It aims to effectively and compliantly utilize market value management tools while enhancing communication with various market participants to convey the company's value [1] Group 2: Operational Focus - The company is committed to improving operational performance to enhance quality and internal value [1] - The strategy for market value management is based on the scientific coordination and steady advancement of operational improvements to boost shareholder return capabilities [1]

德展健康（000813.SZ）8月11日在投资者互动平台表示，WYY是公司自主研发的一类创新药项目，是 主要用于治疗脑卒中的神经保护剂。目前公司正在进行WYY注射剂型的IND申报准备，计划本年度内 提交IND申请，同时公司正积极推进WYY舌下片剂型的研究。后续公司将根据相关事项进展情况，依 据法规要求及时履行披露义务。 （文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：WYY是公司自主研发的一类创新药项目？请问WYY一 类创新药进展情况如何？ ...

每经AI快讯，有投资者在投资者互动平台提问：创新药大麻二酚（CBD）相关项目进展如何？ 德展健康（000813.SZ）8月11日在投资者互动平台表示，公司子公司德义制药在研小分子大麻素创新药 目前尚处于临床前研究阶段。公司正与杨宝峰院士一道，依托院士专家工作站，积极推进大麻素创新药 领域药品研发工作，后续研发进展公司会依据法规要求及时予以披露。 （文章来源：每日经济新闻） ...

Group 1 - The company has added 14 new drugs for domestic production on its official website, which are mature products that have already obtained production licenses [2] - The company has not received any new production licenses as of 2025 and will continue to focus on new drug research and development [2] - The company aims to provide more high-quality treatment options for patients [2]

| 300723 | 一品红 | -1.57 | 1.53 | -3283.59 | | --- | --- | --- | --- | --- | | 600812 | 华北制药 | -1.79 | 1.56 | -3211.05 | | 603707 | 健友股份 | -1.57 | 1.13 | -3199.60 | | 000513 | 丽珠集团 | -1.18 | 1.89 | -2646.84 | | 688266 | 泽璟制药 | -1.79 | 1.22 | -2023.83 | | 688687 | 凯因科技 | -1.23 | 5.23 | -1814.98 | | 688238 | 和元生物 | -2.26 | 2.31 | -1499.70 | | 002007 | 华兰生物 | -0.66 | 0.83 | -1452.56 | | 600645 | 中源协和 | -2.15 | 2.61 | -1354.50 | | 600223 | 福瑞达 | -0.35 | 1.25 | -1245.76 | | 688136 | 科兴制药 | -2.66 | 3.70 | -788.30 | ...